Equities

China Biotech Services Holdings Ltd

China Biotech Services Holdings Ltd

Actions
  • Price (EUR)0.0365
  • Today's Change-0.005 / -10.98%
  • Shares traded20.00k
  • 1 Year change-23.96%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 11:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7293152
Total Receivables, Net36761108
Total Inventory9.27194.74
Prepaid expenses5.834.751.57
Other current assets, total1387.1511
Total current assets261885278
Property, plant & equipment, net124129105
Goodwill, net107110121
Intangibles, net586781
Long term investments5799122
Note receivable - long term------
Other long term assets----0
Total assets6621,470707
LIABILITIES
Accounts payable5.7920616
Accrued expenses237728
Notes payable/short-term debt855.6456
Current portion long-term debt/capital leases9.83117.58
Other current liabilities, total36248119
Total current liabilities159549227
Total long term debt5.73653.56
Total debt1008267
Deferred income tax6.447.899.94
Minority interest2822470
Other liabilities, total--220
Total liabilities200868311
SHAREHOLDERS EQUITY
Common stock969696
Additional paid-in capital491491491
Retained earnings (accumulated deficit)(85)18(239)
Treasury stock - common--00
Unrealized gain (loss)(18)8.0243
Other equity, total(21)(11)4.73
Total equity463603395
Total liabilities & shareholders' equity6621,470707
Total common shares outstanding963963963
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.